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Personalized Depression Prevention: A Randomized
Controlled Trial to Optimize Effects Through
Risk-Informed Personalization
Jami F. Young, PhD , Jason D. Jones, PhD , Robert Gallop, PhD , Jessica S. Benas, PhD,
Christie M. Schueler, PhD , Judy Garber, PhD , Benjamin L. Hankin, PhD
Objective: To evaluate whether evidence-based depression prevention programs can be optimized by matching youths to interventions that address
their psychosocial vulnerabilities.
Method: This randomized controlled trial included 204 adolescents (mean [SD] age ¼ 14.26 [1.65] years; 56.4% female). Youths were categorized as
high or low on cognitive and interpersonal risks for depression and randomly assigned to Coping With Stress (CWS), a cognitive-behavioral program, or
Interpersonal Psychotherapy–Adolescent Skills Training (IPT-AST), an interpersonal program. Some participants received a match between risk and
prevention (eg, high cognitive–low interpersonal risk teen in CWS, low cognitive–high interpersonal risk teen in IPT-AST), others received a mismatch
(eg, low cognitive-high interpersonal risk teen in CWS). Outcomes were depression diagnoses and symptoms through 18 months postintervention (21
months total).
Results: Matched adolescents showed significantly greater decreases in depressive symptoms than mismatched adolescents from postintervention
through 18-month follow-up and across the entire 21-month study period (effect size [d] ¼ 0.44, 95% CI ¼ 0.02, 0.86). There was no significant
difference in rates of depressive disorders among matched adolescents compared with mismatched adolescents (12.0% versus 18.3%, t193 ¼ .78,
p ¼ .44).
Conclusion: This study illustrates one approach to personalizing depression prevention as a form of precision mental health. Findings suggest that
risk-informed personalization may enhance effects beyond a one-size-fits-all approach.
Clinical trial registration information: Bending Adolescent Depression Trajectories Through Personalized Prevention; https://www.clinicaltrials.
gov/; NCT01948167.
Key words: depression, personalization, precision, prevention
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epression is prevalent and the leading cause of
disability worldwide.1 Symptoms and diagnoses
increase during adolescence,2 and adolescent-
onset depression increases risk for recurrence of depression
in adulthood.3 Depression is undertreated,4 and existing
treatments reduce only one third of the burden of depres-
sion.5 Preventive interventions can reach a larger number of
people and may reduce the burden and prevalence of
depression.6,7 Several youth depression prevention programs
have been developed and tested. One cognitive-behavioral
program with strong evidence of efficacy is Coping With
Stress (CWS), which targets cognitive risks for depression.
CWS decreases depressive symptoms and prevents disorder
onset compared with usual care among at-risk adolescents.8-12
A second evidence-based prevention program is Interpersonal
Psychotherapy–Adolescent Skills Training (IPT-AST),13
which targets interpersonal risks. IPT-AST prevents depres-
sion diagnoses, reduces symptoms, and improves overall
functioning among adolescents with elevated depressive
symptoms.14-16 Meta-analyses indicate that both programs
are efficacious, particularly in selective and indicated
samples.17,18 However, effects for these and other depression
prevention programs are small to moderate with limited
evidence of sustained effects beyond 1-year follow-up in
meta-analyses17 (for exceptions, see references8,9).
One explanation for these relatively modest effects is
that prevention programs are based on a one-size-fits-all
approach in which all youths are assigned to an interven-
tion that teaches skills to reduce a set of vulnerabilities (eg,
cognitive risks) regardless of an individual youth’s risk
D
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profile. The assumption underlying this one-size-fits-all
approach is that a single-modality program benefits all re-
cipients equally. It is possible, however, that these programs
are more effective for youths who exhibit risk targeted by a
given intervention (ie, a match between a youth’s risk
profile and the prevention program), but are less effective
for youths without these vulnerabilities (ie, a mismatch
between a youth’s risk profile and the prevention program).
Given the modest effects of one-size-fits-all prevention
approaches, one possible avenue for optimizing outcomes
(eg, enhancing effect sizes, lengthening effects, reducing
prevalence) is a personalized, or precision mental health,
approach. There has been a call to use risk markers to
stratify individuals and identify who will respond better to a
particular intervention.19,20 For depression prevention,
personalization could involve assessing evidence-based vul-
nerabilities (eg, cognitive and interpersonal risks) and
matching an individual’s risk profile to a prevention pro-
gram that addresses these vulnerabilities.
Preliminary evidence supports a personalized approach
to depression prevention by matching youths to programs
based on their risk profiles. Adolescents with high negative
attributional style (cognitive risk) exhibited a 5-fold reduc-
tion in disorder onset when receiving cognitive-focused
bibliotherapy compared with other interventions.21
Youths with high mother–child conflict (interpersonal
risk) who received IPT-AST showed greater decreases in
depressive symptoms than adolescents with high conflict
who received school counseling.22 However, these findings
are based on post hoc moderation analyses. To more
rigorously test the potential benefits of personalization, a
clinical trial design is needed in which youths are assessed
for empirically supported risks, a priori matched or mis-
matched to prevention, and evaluated over time.23
To test the benefits of personalized depression preven-
tion (PDP), we embarked on such a randomized controlled
trial. Youths in PDP were matched or mismatched to 2
evidence-based depression prevention programs (CWS and
IPT-AST) that target particular depression risks. We spe-
cifically examined whether outcomes of these programs
could be improved by matching youths to the prevention
program that best addresses their psychosocial vulnerabil-
ities. These findings can provide vital information on pre-
scriptive indicators24 about which particular prevention
program is likely to be of most benefit to given adolescents.
We used a validated risk classification system25 to categorize
youths as high or low on cognitive and interpersonal risks.
We focused on select cognitive (negative cognitive style,
dysfunctional attitudes, rumination) and interpersonal
(parent–adolescent conflict, low peer support) risks because
these are empirically supported vulnerabilities for depres-
sion26-28 and are targeted in CWS or IPT-AST.
At baseline we measured cognitive and interpersonal
vulnerabilities to assign youths to 1 of 4 risk groups (high or
low cognitive and/or interpersonal risks). Following risk
classification, adolescents in each of the 4 risk groups were
randomly assigned to either CWS or IPT-AST. For key risk
groups, about half of participants were randomly assigned to
receive a match between their risk profile and the preven-
tion program (eg, high cognitive–low interpersonal risk
randomly assigned to CWS), whereas the other half were
randomly assigned to receive a mismatch (eg, high
cognitive–low interpersonal randomly assigned to IPT-
AST). This design enabled us to empirically test how
matching and mismatching adolescents to different
evidence-based programs that target particular depression
risks would lead to differential depression outcomes through
18 months post-intervention. Whereas we expected no
difference in outcomes between CWS and IPT-AST across
the entire sample (ie, average of all 4 risk groups), we hy-
pothesized that adolescents receiving a match between risk
classification and prevention (high cognitive risk–low
interpersonal risk youths receiving CWS, low cognitive
risk–high interpersonal risk youths receiving IPT-AST)
would show significantly lower rates of disorder and
reduced symptom trajectories compared with youths
receiving nonpersonalized prevention (high cognitive–low
interpersonal risk youths receiving IPT-AST, low
cognitive–high interpersonal risk youths receiving CWS).
METHOD
Participants
This 2-site randomized controlled trial included a sample of
204 youths recruited from the general community (94
enrolled in New Jersey and 110 enrolled in Colorado). Age
of adolescents ranged from 11 to 18 years (mean [SD] ¼
14.26 [1.65] years); the sample was 56.4% female. Racial
minorities accounted for 29% of participants; 18.1% were
Hispanic/Latino. Eligibility criteria included being in grades
6–12 and adolescent and parent were English-speaking.
Exclusion criteria at baseline included current major
depressive disorder (MDD), dysthymia, bipolar disorder, or
psychosis or active suicidal ideation or a recent suicide
attempt.
Procedures
All participants completed a baseline evaluation. Measures
of cognitive and interpersonal risk factors were used to
assign participants to a risk classification: 26% were low
cognitive–low interpersonal risk, 26% were high
Journal of the American Academy of Child & Adolescent Psychiatry www.jaacap.org 1117
Volume 60 / Number 9 / September 2021
PERSONALIZED DEPRESSION PREVENTION
cognitive–high interpersonal risk, 25% were low
cognitive–high interpersonal risk, and 23% were high
cognitive–low interpersonal risk. Broadly, these replicate
percentages in the original risk classification work.24
Within each risk classification group, we stratified on
gender and used a computer-generated random numbers
sequence to assign youths to CWS (n ¼ 101) or IPT-
AST (n ¼ 103). Figure 1 illustrates the allocation to
intervention condition and flow of participants. All par-
ticipants were considered part of the study after ran-
domized (intent-to-treat design).
The institutional review boards of both study sites
approved the study, which was registered at ClinicalTrials.
gov (NCT01948167) (see Supplement 1, available on-
line). Recruitment, outcomes, and adverse events were
monitored by a data and safety monitoring board. Parents
provided written consent, and adolescents provided written
assent.
Intervention Conditions
Coping With Stress. We used the Prevention of Depression
study manual.12 CWS consisted of 8 weekly group sessions
(90 minutes each), 2 parent group sessions (90 minutes
each), and 3 booster sessions (60 minutes each) in the 6
months following group sessions. CWS teaches teenagers to
identify negative thoughts, evaluate accuracy of these
thoughts, and generate alternative thoughts. Adolescents
also learn problem-solving skills. During booster sessions,
cognitive restructuring and/or problem-solving skills were
reviewed, and additional modules (more problem solving,
relaxation, assertiveness, and behavioral activation) could be
introduced.
FIGURE 1 CONSORT Diagram
Note: Low/Low ¼ low cognitive–low interpersonal; High Cog/Low Int ¼ high cognitive–low interpersonal; Low Cog/High Int ¼ low cognitive–high interpersonal; High/
High ¼ high cognitive–high interpersonal.
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There were 20 CWS groups including 2–8 participants
with a mean (SD) of 4.50 (1.70) adolescents per group.
Adolescents attended 80% of the group sessions and 84% of
the booster sessions. The first parent session was attended
by 78% of parents, and 81% attended the second session.
All groups had 2 graduate student leaders. Leaders read the
CWS manual, attended a 1-day workshop, and completed a
mock group or listened to recordings of other CWS groups.
All CWS sessions were audio recorded. An experienced
CWS supervisor listened to at least 50% of group and
booster sessions as part of weekly supervision and rated
session fidelity (adherence to session content and quality of
techniques) using a CWS checklist. Adherence (96.4%) and
quality (96.6%) were high. Another CWS supervisor rated
10% of randomly selected sessions; intraclass correlation
coefficients for interrater reliability were 0.88 for adherence
and 0.89 for quality.
Interpersonal Psychotherapy–Adolescent Skills Training. In
PDP, IPT-AST consisted of 1 pregroup session (90 minutes),
which parents were invited to attend; 8 weekly group sessions
(90 minutes each); an individual midgroup session, which
parents were invited to attend (60 minutes); and 3 individual
booster sessions (60 minutes each) in the 6 months following
group sessions.13 During the pregroup session, adolescents’
relationships are reviewed and interpersonal goals
identified. In group sessions, youths discuss links between
relationships and mood, learn different communication stra-
tegies, and apply these strategies to improve their relation-
ships. In the midgroup and booster sessions, interpersonal
strategies are reviewed and applied to current relationship
problems.
There were 20 IPT-AST groups including 3 to 8 par-
ticipants (mean [SD] 4.85 [1.57] adolescents). Adolescents
attended 87% of the group sessions and 88% of the booster
sessions. All adolescents attended the pregroup session, and
98% attended the midgroup session. All groups had 2
graduate student leaders. Training for IPT-AST leaders
mirrored the training described above for CWS. An expe-
rienced IPT-AST supervisor listened to at least 50% of
group and individual sessions as part of weekly supervision
and rated session fidelity using the IPT-AST supervision
checklist (unpublished measure, 2005). Adherence (99.4%)
and quality (96.6%) were high. Another IPT-AST super-
visor rated 10% of randomly selected sessions for reliability;
intraclass correlation coefficients were 0.86 for adherence
and 0.89 for quality.
Measures
Depression Diagnoses. Depression diagnoses were assessed
by trained independent evaluators (IEs) who administered
the Schedule for Affective Disorders and Schizophrenia for
School-Age Children–Present and Lifetime version (K-
SADS-PL)29 to adolescents and parents at baseline; imme-
diately postintervention; and 6, 12, and 18 months post-
intervention. IEs (research assistants or graduate students)
used youth and parent reports on the K-SADS-PL to
determine youths’ diagnostic status using best estimate
diagnostic procedures.30 Adolescents were deemed to have a
current or past depressive episode if they met DSM-IV
criteria for MDD-definite or MDD-probable (4 threshold
symptoms with at least 2 weeks duration and significant
distress/impairment).
IEs were highly reliable (k ¼ 0.96 for 10 practice cases;
k ¼ 0.94 for 10% of randomly selected completed evalu-
ations). IEs were naïve to intervention condition. When the
masking was broken, adolescents were assigned a new IE.
IEs guessed participants’ intervention assignment after
completing evaluations. The mean correct classification rate
was 47.5%, or chance level, providing evidence that IEs
remained naïve to intervention condition.
Depression Symptoms. Depression symptoms were assessed
with the Children’s Depression Inventory (CDI),31 which
was completed at baseline, midintervention; immediately
postintervention; and 6, 12, and 18months postintervention.
Cronbach’s a across administrations ranged from .81
to .91.
Cognitive and Interpersonal Risks. Cognitive and inter-
personal risks at baseline were assessed by 3 cognitive
measures and 2 interpersonal measures.25 Youths were
classified as high cognitive risk if they scored above the
cutoff on any of the following 3 cognitive measures: 3.4 or
higher on the Adolescent Cognitive Style Questionnaire
(ACSQ),32 a valid measure of negative cognitive style33
(a ¼ .92); 36 or higher on the Children’s Dysfunctional
Attitudes Scale (CDAS),34 a validated measure of dysfunc-
tional attitudes35 (a ¼ .86); or 29 or higher on the rumi-
nation subscale of the Children’s Response Styles
Questionnaire (CRSQ),26,36 (a ¼ .92).
Youths were classified as high interpersonal risk if they
had high parent–adolescent conflict and/or low peer support
as measured by the Network of Relationships Inventory
(NRI).37 A parent conflict score (both parents averaged) of
15.5 or higher (a ¼ .93 for mother conflict; a ¼ .91 for
father conflict) and/or a score of 23 or below on same-sex peer
support (a ¼ .86) indicated interpersonal risk.
Data Analysis
All models were fit using SAS 9.4.38 To examine differences
on depression diagnoses, we modeled diagnosis (presence
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versus absence during the 21-month study window) using
logistic regression. For depressive symptoms, we imple-
mented a 2-level hierarchical linear model to examine dif-
ferences on symptom change over time. The first level
models individual scores over time. At the second level,
individual intercepts and slopes are analyzed as outcomes
within IPT-AST and CWS. We conducted a piecewise hi-
erarchical linear model to evaluate change within 2 legs of
time in addition to overall change over the 21 months:
change from baseline to postintervention (3 months post-
baseline) and change from postintervention through the 18-
month follow-up. Degrees of freedom were estimated with
the Kenward-Roger approximation.39 For effect sizes, we
present proportions, odds ratios (ORs), and incidence rate
ratios (IRRs) for binary variables and d for continuous
variables.
For our primary hypotheses regarding personaliza-
tion, comparisons within risk classifications were evalu-
ated through linear contrasts using the logistic regression
models for diagnosis and fitted hierarchical linear models
for symptoms, focusing on comparing the off-diagonal
risk classification groups (high cognitive–low interper-
sonal risk and low cognitive–high interpersonal risk).
We compared high cognitive–low interpersonal risk
adolescents who received CWS (match) with high
cognitive–low interpersonal risk adolescents who
received IPT-AST (mismatch) and low cognitive–high
interpersonal risk adolescents randomly assigned to
IPT-AST (match) with low cognitive–high interpersonal
risk adolescents randomly assigned to CWS (mismatch).
Consistent with our design to evaluate personalization a
priori via matching and mismatching, half (51%) of
adolescents in these 2 groups received a match between
their risk classification and prevention assignment,
and half (49%) received a mismatch. To further eval-
uate the potential benefits of matching, we performed
additional analyses comparing all adolescents who
received a matched intervention across these 2 risk
classifications (high cognitive–low interpersonal risk in
CWS; low cognitive–high interpersonal risk in IPT-
AST) with adolescents in these 2 groups who received
a mismatch.
With a proposed sample of 135 in the off-diagonal
groups, we had 83.3% power to detect a difference of
25% in diagnoses; with 98 adolescents in the off-
diagonal groups, power was 71.2% to detect this
difference. For symptoms, power was calculated for the
clustered design using estimates based on prior preven-
tion studies.8-12,14-18,21,22 Power was 82.9% to detect a
moderate effect size with a sample of 135. With the
observed sample size, we had 78.4% power to detect
moderate effects. We included covariates if a variable was
imbalanced across intervention conditions within the
risk classification groups. Only age (p ¼ .003) and
ethnicity (p ¼ .10) were imbalanced across risk classifi-
cations and were included as covariates. Additionally, we
included lifetime depression history, using a broad
definition that included MDD, MDD-probable, or mi-
nor depressive disorder (2 or 3 threshold symptoms with
at least 2 weeks’ duration and significant distress/
impairment), as a covariate, as it was significantly asso-
ciated with outcomes. There were no differences be-
tween study sites on baseline diagnoses, symptoms, or
lifetime diagnoses (p  .33).
RESULTS
Preliminary Analyses
Table 1 provides descriptive statistics. Among adolescents
who received the allocated intervention, retention rates
through 18-month follow-up were 92% in IPT-AST and
91% in CWS. One participant in the low cognitive–high

















34.8 37.9 31.7 .35
Risk classification measures at baseline
Negative cognitive
style (ACSQ)
2.78 (0.82) 2.86 (0.75) 2.69 (0.89) .15
Dysfunctional
attitudes (CDAS)
32.25 (7.31) 33.07 (7.45) 31.42 (7.10) .11
Rumination (CRSQ) 23.62 (8.13) 23.95 (8.45) 23.29 (7.82) .56
Parenteadolescent
conflict (NRI)
12.62 (4.75) 12.29 (4.81) 12.95 (4.69) .33
Peer support (NRI) 25.95 (6.01) 25.80 (5.57) 26.10 (6.46) .73
Note: Values are reported as mean (SD) except where noted. ACSQ ¼
Adolescent Cognitive Style Questionnaire; CDAS ¼ Children’s
Dysfunctional Attitudes Scale; CDI ¼ Children’s Depression Inventory;
CRSQ ¼ Children’s Response Styles Questionnaire; CWS ¼ Coping
With Stress; IPT-AST ¼ Interpersonal Psychotherapy–Adolescent
Skills Training; K-SADS-PL ¼ Schedule for Affective Disorders and
Schizophrenia for School-Age Children–Present and Lifetime version;
MDD ¼ major depressive disorder; NRI ¼ Network of Relationships
Inventory.
aLifetime depression diagnosis includes MDD definite, MDD probable,
and minor depression.
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interpersonal risk class withdrew from CWS. The 3 par-
ticipants who withdrew from IPT-AST belonged to the
following classifications: high cognitive–low interpersonal,
low cognitive–high interpersonal, and high cognitive–high
interpersonal. Pattern-mixture models40 indicated that
intervention effects were not dependent on patterns of
missing data (p > .14 for CDI, p > .68 for diagnosis). CDI
scores required square root transformation to guarantee
multivariate normality of the residuals.
Overall Intervention Effects
Across the whole sample (ie, all 4 risk classifications), as
expected, rates of depression diagnoses did not differ be-
tween the 2 interventions: 14.4% in CWS and 18.2% in
IPT-AST (t198 ¼ 0.69, p ¼ .49). Similarly, there were no
significant differences between CWS and IPT-AST in
change in depressive symptoms (p > .55).
Personalized Prevention Effects
Although low cognitive–high interpersonal risk youths
matched to IPT-AST showed lower rates of depression di-
agnoses compared with youths who received CWS (9.5%
versus 25.2%), this difference fell short of statistical signif-
icance (t193 ¼ 1.30, p ¼ .20, OR ¼ 3.22 [95% CI ¼ 0.54,
19.11], IRR ¼ 0.38 [95% CI ¼ 0.08, 1.81]). For high
cognitive–low interpersonal risk youths, rates of depression
diagnoses were 19.6% in CWS and 19.9% in IPT-AST
(t193 ¼ 0.02, p ¼ .99, OR ¼ 0.99 [95% CI ¼ 0.20,
4.89], IRR ¼ 0.99 [95% CI ¼ 0.30, 4.18]). See Supple-
ment 2, available online, for rates among other groups.
Across these 2 risk groups, matched adolescents had
nonsignificantly lower rates of diagnoses than mismatched
adolescents, 12.0% versus 18.3% (t193 ¼ 0.78, p ¼ .44,
OR ¼ 1.65 [95% CI ¼ 0.46, 5.85], IRR ¼ 0.65 [95%
CI ¼ 0.29, 2.29]).
FIGURE 2 Depressive Symptom Trajectories by Risk Classification Groups for the Different Intervention Modalities to Test
Personalization by Matching and Mismatching
Note: CWS ¼ Coping With Stress; IPT-AST ¼ Interpersonal Psychotherapy–Adolescent Skills Training.
Journal of the American Academy of Child & Adolescent Psychiatry www.jaacap.org 1121
Volume 60 / Number 9 / September 2021
PERSONALIZED DEPRESSION PREVENTION
Figures 2 and 3 illustrate trajectories of depressive
symptoms by intervention condition, focusing on the 2 risk
classification groups of interest, using observed data at each
time point to graph the trajectories. Table 2 provides the
model-based estimates and contrasts for the high-low/low-
high risk groups that provide the essential tests relevant to
evaluate personalization and the contrasts for matched
versus mismatched youths in these 2 risk groups (see
Table S1, available online, for other risk groups).
Low cognitive–high interpersonal risk adolescents
matched to IPT-AST showed significantly greater decreases
in depressive symptoms over 21 months than adolescents in
this risk group who received CWS. High cognitive–low
interpersonal risk adolescents matched to CWS showed
significantly greater decreases in depressive symptoms from
postintervention through 18 months than adolescents in
this risk group who received IPT-AST. Matched adolescents
showed significantly greater decreases in depressive symp-
toms than mismatched adolescents from postintervention
through 18-month follow-up and across the entire 21-
month study period.
DISCUSSION
The PDP study examined a novel approach to personalizing
depression prevention. Specifically, we investigated whether
youths who received an intervention consistent with their
risk classification showed better outcomes (ie, lower rates of
disorder onset and fewer depressive symptoms) compared
with youths mismatched between modality and risk profile.
We replicated in this independent PDP sample our previ-
ously validated risk classification system25 and applied this
system to categorize adolescents on depression risk based on
documented cognitive and interpersonal vulnerabilities. We
then randomly assigned youths within each risk classifica-
tion group to IPT-AST or CWS, 2 programs with prior
evidence of efficacy. CWS teaches skills to reduce cognitive
risk, and IPT-AST emphasizes strategies to address inter-
personal vulnerabilities. For our primary aim to examine the
benefits of personalization, we focused on adolescents
exhibiting low cognitive–high interpersonal risk and
exhibiting high cognitive–low interpersonal risk. This
enabled us to directly evaluate, a priori, the hypothesized
effect of personalization of depression prevention by
comparing prospective depression outcomes for adolescents
who received a matched prevention program compared with
adolescents who received a mismatch. We supplemented
these analyses by examining whether adolescents who
received a matched intervention across these 2 risk classifi-
cation groups had better outcomes than adolescents who
received a mismatch.
FIGURE 3 Depressive Symptom Trajectories by Matching and Mismatching
1122 www.jaacap.org Journal of the American Academy of Child & Adolescent Psychiatry
Volume 60 / Number 9 / September 2021
YOUNG et al.
Partially in line with study hypotheses and in support of
precision mental health approaches, adolescents classified as
low cognitive–high interpersonal risk for depression who
received IPT-AST (a match between risk profile and pre-
vention modality) showed better long-term depression
outcomes (medium, but nonsignificant, effect for diagnoses;
significant reduction in symptoms) than adolescents in this
group who received CWS (a mismatch between risk and
prevention). Adolescents classified as high cognitive–low
interpersonal risk for depression who received the
matched prevention program (CWS) improved on depres-
sive symptom trajectories during the follow-up period,
although there was no significant difference in diagnosis
rates. Supplemental analyses further suggest the potential
benefits of matching youths to prevention program,
particularly for symptoms. Taken together, our results
support the value of assessing depression vulnerabilities to
determine which evidence-based prevention program
(cognitive-behavioral or interpersonal) to offer adolescents.
In the overall sample, there were no significant differ-
ences in outcomes between youths who received IPT-AST
or CWS. We did not expect a difference between
these prevention programs for the average youth, repre-
senting the one-size-fits-all approach and analysis, because
the literature documents relative equal efficacy of both
programs.8-12,14-16,41 Additionally, prior work found no
significant difference in depressive symptoms between CWS
and IPT-AST in a universal sample of adolescents.42
Importantly, and in line with our primary hypothesis, we
found some evidence of differential effects of these programs
in the matched versus mismatched risk classification groups.
We observed some indication that matching youths to
prevention programs based on risk leads to differential rates
of depression onset over 18-month follow-up. This was the
case only for youths at low cognitive–high interpersonal risk
who received IPT-AST compared with CWS. The odds of
experiencing a depressive disorder were 3.2 times greater for
youths who received a mismatched intervention (CWS)
compared with youth in IPT-AST, although this difference
was not statistically significant. Additionally, the IRR was
0.38, indicating a 62% reduction in prospective depressive
disorder when high interpersonal risk youths were matched
to IPT-AST. Meta-analysis of depression prevention on
average, for one-size-fits-all approaches, reveals an IRR of
0.78, meaning a 22% reduction in depression diagnosis
when receiving prevention without risk consideration.43
This highlights a potential opportunity to augment the
preventive effects of IPT-AST by providing this program to
youths who are at risk for depression by virtue of high
parent–child conflict and/or low peer support.
TABLE 2 Change in Depressive Symptoms Over Follow-up for Key Off-Diagonal Risk Classification Groups to Test
Personalization by Intervention Matching
Estimated change Intervention contrast Effect size
CWS (SE) IPT-AST (SE) t df p d (95% CI)
High cognitive risk-low
interpersonal risk (n [ 47)
n [ 23 n [ 24
Leg 1 change D1.00 (1.25) L0.06 (1.41) 1.64 193 .10 0.38 (L0.02, 0.77)
Leg 2 change L1.90 (1.49) D2.82 (1.17)* L2.68 193 .01 0.64 (0.24, 1.04)
Total change L0.90 (1.64) D2.76 (2.04) L1.18 193 .24 0.30 (L0.09, 0.68)
Low cognitive riskehigh
interpersonal risk (n [ 51)
n [ 24 n [ 27
Leg 1 change L2.26 (1.31)† L1.52 (0.60)* 0.59 193 .56 0.13 (L0.25, 0.51)
Leg 2 change D2.92 (1.10)** D1.12 (1.35) 1.25 193 .21 0.28 (L0.11, 0.66)
Total change D0.66 (1.17) L0.40 (1.25) 1.98 193 .049 0.51 (0.12, 0.90)
Estimated change Contrast Effect size
Match (SE) Mismatch (SE) t df p d (95% CI)
Match vs. mismatch (n [ 98) n [ 50 n [ 48
Leg 1 change L0.27 (0.26) L1.17 (0.54)* 0.82 193 .41 0.16 (L0.26, 0.58)
Leg 2 change L0.41 (1.45) D2.87 (0.83)*** L2.80 193 .01 0.57 (0.16, 1.02)
Total change L0.67 (0.47) D1.70 (1.17) L2.17 193 .03 0.44 (0.02, 0.86)
Note: The significance patterns under estimated change refer to within intervention change for the particular time frames (ie, leg 1, leg 2, total
change). CWS ¼ Coping With Stress; IPT-AST ¼ Interpersonal Psychotherapy–Adolescent Skills Training.
*p < .05; **p < .01; ***p < .001; †p < .10.
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We did not see differential rates of depression onset in
adolescents at high cognitive–low interpersonal risk for
depression randomly assigned to CWS or IPT-AST.
Although we did not find evidence that personalization
enhanced the effects of CWS on depression diagnoses, our
study and past trials show effects of CWS for reducing
depression onset.8-11 Furthermore, the analyses combining
the matched adolescents across these 2 risk classification
groups suggest potential, albeit modest, benefits of match-
ing youths to prevention program on rates of depression
onset. Across these 2 classification groups, the odds of
experiencing a depressive disorder were 1.7 times greater for
youths who received a mismatched intervention compared
with a matched intervention. Although the difference in
rates is not significant, there was a 35% reduction in pro-
spective depressive disorder when adolescents received a
matched intervention. This compares favorably to the 22%
reduction in a meta-analysis in which most studies
compared an active prevention program with a no-
intervention control group.43
PDP also showed differential effects on depressive
symptoms. Youths who received a matched preventive
intervention experienced relatively stable symptoms or a
modest decrease in symptoms over time, whereas youths
who received a mismatch experienced a small increase in
depressive symptoms. The differences in rates of change
were small, and these differences were not consistent
across the 2 risk groups. In the low cognitive–high
interpersonal risk group, we found a significant differ-
ence across the entire 21-month study period, whereas
in the high cognitive–low interpersonal risk group the
significant difference was in the 18-month follow-up
period when CWS youths showed a decline in depres-
sive symptoms and IPT-AST youths showed an increase
in symptoms. In the matched versus mismatched ana-
lyses across the 2 classification groups, there were sig-
nificant differences across the follow-up and the entire
21-month study period.
This sample had relatively low levels of baseline
depressive symptoms compared with prior indicated
prevention studies, which enrolled youths with elevated
symptoms. This may explain the lack of significant
differences during the active phase of the intervention,
as there was limited room for improvement. Addition-
ally, neither intervention changed symptoms in the high
cognitive–low interpersonal risk group in the active
phase of the intervention (baseline to postintervention),
whereas the low cognitive–high interpersonal group
exhibited change under both interventions. This suggests
that early change may be harder to achieve in the high
cognitive risk group, with stable negative beliefs
conferring vulnerability, whereas the high interpersonal
risk group may be more amenable to early change.
Future research can evaluate the hypothesis that youths
with elevated cognitive risks are more resistant to
intervention effects in the short-term relative to youths
with interpersonal risks.
Over time, the high cognitive–low interpersonal risk
group improves over the follow-up period with the right
intervention matched to their risk, whereas with a mis-
matched intervention these high cognitive risk youths
experienced deteriorating symptom trajectories over time.
Likewise, the high interpersonal risk group maintained the
early gains over longer follow-up when matched to IPT-
AST, whereas symptoms worsened over time when mis-
matched to CWS. So, in the follow-up phase, mismatched
adolescents showed a statistically significant increase in
depression symptoms, whereas adolescents who received a
matched intervention either showed modest reductions in
symptoms or exhibited more stability via lack of significant
increases in symptoms. Finding these longer-term preven-
tion effects for adolescents who received an intervention
targeting their particular vulnerabilities compared with ad-
olescents who received a mismatch to another evidence-
based intervention underscores the potential of
personalization.
These findings are in line with post hoc moderator
analyses from previous depression prevention studies.21,22
Cognitive risk moderated outcomes for cognitive-
behavioral prevention programs, and parent–adolescent
conflict moderated outcomes for IPT-AST. Importantly,
PDP is the first study to a priori match or mismatch
youths to a prevention program based on cognitive and
interpersonal risks. Our findings suggest that providing a
personalized program may increase the magnitude and
length of the effects of these evidence-based programs.
These findings provide preliminary prescriptive in-
dicators24 about which program may be most helpful for
a given adolescent.
Taken together, the findings from PDP provide initial
evidence that personalization, focused on cognitive and
interpersonal vulnerabilities for depression, may enhance
the effects of evidence-based depression prevention pro-
grams. Other groups have examined different individualized
metrics that help quantify the benefits a person will receive
from one or another intervention.20 These include the
Personalized Advantage Index (PAI)44 and the Probability
of Treatment Benefit (PTB)45; evidence supports both
metrics.46,47 Randomized controlled trials that prospectively
match individuals to their optimal intervention based on
these metrics and then examine outcomes will be an
important next step for PAI and PTB.20 We believe these
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and other personalization approaches provide promising
solutions to move the field forward.
Limitations of this study should be noted. First, PDP
adolescents were recruited from the general community.
Although results are generalizable to the broader youth
population, this approach resulted in a sample with
relatively low baseline levels of depressive symptoms,
particularly in comparison to indicated samples in prior
CWS and IPT-AST studies. This likely limited our ability
to detect changes over time in depressive symptoms,
especially in the active phase of the intervention; we
observed statistically significant symptom changes, but
these changes may have less clinical significance. Second,
more than a third of the sample had experienced a prior
depressive episode using a broad definition (MDD-defi-
nite, MDD-probable, or minor depression), which may
impact generalizability to other samples and past pre-
vention findings. Our findings therefore reflect both pri-
mary and relapse prevention. Finally, although the overall
study was sufficiently powered to detect effects on di-
agnoses and symptoms, we had modest power for these
analyses. As a first examination of personalizing preven-
tion, we had to make necessary decisions to ensure study
feasibility. Future research can build on these novel
findings and intentionally select youths based on these
risk classification groups with larger sample sizes and a
no-intervention comparison condition to more robustly
evaluate personalization via matching to prevention
modality.
In conclusion, results from the PDP study provide
preliminary a priori evidence of the benefits of personalizing
depression prevention to optimize effects in a sample of
diverse youths at risk for depression by virtue of cognitive or
interpersonal vulnerabilities. Although results are prom-
ising, they should be viewed cautiously given that this is the
first time this approach to matching has been evaluated, risk
group sample sizes are modest, and there is variation in
results. Replication with larger samples is warranted. Pre-
ventive interventions may need to address multiple risk and
protective factors for depression to optimize effects48 or
include other approaches to personalized interventions.20
Given the increasing rates of depression during
adolescence, the significant risks and impairment associated
with adolescent-onset depression, and the clear promise of
prevention, it is essential to try to optimize depression
prevention programs and disseminate these efforts so that
they can inform clinical decision making. This will ensure
that more youths can receive an evidence-based prevention
program that is likely to be most beneficial for them,
reducing the burden of depression for both the individual
and society.
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Depressive symptoms was an a priori primary outcome
measure, but was erroneously listed as a secondary outcome
measure in the original study registration before the
commencement of data collection. This error has been
corrected in the recently updated study registration
(ClinicalTrials.gov NCT01948167).
SUPPLEMENT 2
Intervention Contrasts for Rates of Depression
Diagnoses in Low/Low and High/High Risk Classification
Groups
For low cognitive–low interpersonal risk youths, rates of
depression diagnoses were 9.1% for adolescents who
received CWS and 24.1% for adolescents who received
IPT-AST (t193 ¼ 1.27, p ¼ .20, odds ratio ¼ 0.32 [95%
CI ¼ 0.05, 1.88], incidence rate ratio ¼ 0.38 [95% CI ¼
0.08, 1.81]). For high cognitive–high interpersonal risk
youths, rates of depression diagnoses were 11.3% for ado-
lescents who received CWS and 25.8% for adolescents who
received IPT-AST (t193 ¼ 1.30, p ¼ .19, odds ratio ¼
0.36 [95% CI ¼ 0.08, 1.68], incidence rate ratio ¼ 0.44
[95% CI ¼ 0.12, 1.45]).




CWS (SE) IPT-AST (SE) t df p d (95% CI)
Low cognitive risk-low interpersonal risk
(n [ 53)
n [ 27 n [ 26
Leg 1 change 0.29 (0.48) 0.55 (0.55) L0.34 193 .74 0.08 (L0.30, 0.46)
Leg 2 change 0.63 (0.57) 0.36 (0.64) 0.40 193 .69 0.09 (L0.31, 0.47)
Total change 0.92 (0.50)† 0.90 (0.55) 0.08 193 .94 0.02 (L0.37, 0.40)
High cognitive riskehigh interpersonal risk
(n [ 53)
n [ 27 n [ 26
Leg 1 change L0.28 (1.06) L0.48 (1.05) 0.14 193 .89 0.03 (L0.36, 0.41)
Leg 2 change L0.24 (1.15) L0.80 (0.99) 0.40 193 .69 0.09 (L0.31, 0.47)
Total change L0.52 (1.03) L1.27 (0.94) 0.59 193 .55 0.13 (L0.26, 0.51)
Note: CWS ¼ Coping With Stress; IPT-AST ¼ Interpersonal Psychotherapy–Adolescent Skills Training.
†p < .10.
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